Factors associated with adverse COVID-19 outcomes in patients with psoriasis—insights from a global registry–based study

BACKGROUND: The multimorbid burden and use of systemic immunosuppressants in people with psoriasis may confer greater risk of adverse outcomes of coronavirus disease 2019 (COVID-19), but the data are limited. OBJECTIVE: Our aim was to characterize the course of COVID-19 in patients with psoriasis an...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Allergy Clin Immunol
Main Authors: Mahil, Satveer K., Dand, Nick, Mason, Kayleigh J., Yiu, Zenas Z.N., Tsakok, Teresa, Meynell, Freya, Coker, Bola, McAteer, Helen, Moorhead, Lucy, Mackenzie, Teena, Rossi, Maria Teresa, Rivera, Raquel, Mahe, Emmanuel, Carugno, Andrea, Magnano, Michela, Rech, Giulia, Balogh, Esther A., Feldman, Steven R., De La Cruz, Claudia, Choon, Siew Eng, Naldi, Luigi, Lambert, Jo, Spuls, Phyllis, Jullien, Denis, Bachelez, Hervé, McMahon, Devon E., Freeman, Esther E., Gisondi, Paolo, Puig, Luis, Warren, Richard B., Di Meglio, Paola, Langan, Sinéad M., Capon, Francesca, Griffiths, Christopher E.M., Barker, Jonathan N., Smith, Catherine H.
Formato: Artigo
Idioma:Inglês
Publicado em: Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology 2021
Assuntos:
Covid-19
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7566694/
https://ncbi.nlm.nih.gov/pubmed/33075408
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jaci.2020.10.007
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados